2016
DOI: 10.7860/jcdr/2016/16339.7433
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Renal Allograft Biopsies for Graft Dysfunction and Relevance of C4d Staining in Antibody Mediated Rejection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
6
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 15 publications
1
6
0
Order By: Relevance
“…The earlier study by Devadas also showed similar results and 60% of graft dysfunction was due to acute rejection and 40% of graft dysfunction was due to CNI toxicity, recurrence of primary glomerular disease, acute tubular necrosis and infection. 4 Histopathological pattern of acute rejection in our study showed that antibody-mediated rejection occurred in 50% of recipients, T cell-mediated rejection in 30% of patients and combined antibody mediated and T cell-mediated rejection in 20% of recipients. The earlier studies also showed similar results and antibody-mediated rejection was 87% and T cell-mediated rejection was 13%.…”
Section: Discussionsupporting
confidence: 47%
“…The earlier study by Devadas also showed similar results and 60% of graft dysfunction was due to acute rejection and 40% of graft dysfunction was due to CNI toxicity, recurrence of primary glomerular disease, acute tubular necrosis and infection. 4 Histopathological pattern of acute rejection in our study showed that antibody-mediated rejection occurred in 50% of recipients, T cell-mediated rejection in 30% of patients and combined antibody mediated and T cell-mediated rejection in 20% of recipients. The earlier studies also showed similar results and antibody-mediated rejection was 87% and T cell-mediated rejection was 13%.…”
Section: Discussionsupporting
confidence: 47%
“…Despite modern diagnostic procedures implemented in everyday clinical practice, the kidney allograft biopsy remains a gold standard to determine the cause of graft dysfunction. Biopsy findings change the clinical diagnosis in an average of 36% of patients (range 24-76) and immunosuppressive therapy in 59% [ 15 ] [ 16 ]. But, the allograft biopsy does not contribute only to clinical diagnosis.…”
Section: Introductionmentioning
confidence: 99%
“…Philip et al reported one case of recurrent GN, which was recurrent IgAN (12). Aryal et al, Devadass et al and Puntamekar et al did not observe any recurrent GN (6,14,20). Different studies give disparate clinical presentations of recurrent GN ranging from asymptomatic urinary abnormalities to rapidly progressive GN (21).…”
Section: Discussionmentioning
confidence: 94%
“…CNI Toxicity formed the second largest group, in the present study (19.7%) which is similar to studies by Philip et al (16%) and Aryal et al (28.5%) (6,12). However, in studies by Severova et al and Devadass et al (41.3%), it was the predominant cause of NRI (13,14). The pathogenesis of CNI toxicity is multi-factorial and involves enhanced rennin secretion, relative nitric oxide deficiency, superoxide and peroxynitrite induced injury and loss of vascular endothelial growth factor support to the microvasculature (5).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation